Category Archives: HIV/AIDS

Study highlights “missed opportunities” to prevent HIV infections with PrEP

By on .

In the three years following the U.S. Food and Drug Administration’s approval of a daily oral antiretroviral medicine to prevent HIV infection, records show that 885 South Carolina residents older than 13 were diagnosed with HIV. About two-thirds of them had visited health care facilities before their diagnoses — for a combined total of more […]

WHO releases key population HIV guidelines, with new recommendations for PrEP and opioid overdose management, updated evidence for prison responses, call for law, policy reviews

By on .

Men who have sex with men, incarcerated people, people who inject drugs, people involved in sex work, and transgender people are focus of first consolidated guidelines addressing issues common to all, as well as specific needs They are the people on whom the global AIDS pandemic has had the highest impact, and yet who have […]

HIV transmission risks: Review updates CDC estimates, adds impact of treatment, condom use

By on .

Authors of a comprehensive review of literature reporting data on per-act HIV transmission risks have updated the last estimates produced by the U.S. Centers for Disease Control and Prevention in 2005, and in the process have highlighted the importance of treatment and prevention reaching those at greatest risk. The CDC’s estimates “relied heavily on estimates […]

Making AIDS history, amfAR counts down to a cure at Capitol Hill briefing

By on .

Ambassador Deborah Birx,  Anthony Fauci, Michel Sidibe, Kenneth Cole, Miss Universe, Rep. Nancy Pelosi, Sen. Tom Harkin, and World Bank President Jim Kim among participants in event to “Make AIDS History.” It already sounds like history now, before testing, before treatment, before activism, science, money and policy introduced hope into the time when an AIDS […]

Reports track current progress, pitfalls, funding and gaps of AIDS fight

By on .

On the eve of Secretary Hillary Clinton’s release of the first United States global AIDS response strategy, two reports released in recent days give a look not only of the progress so far, but of the shortfalls the new plan must address. Achieving the End, One Year and Counting, from AVAC, looks at the scientific […]

Study links homophobia, discrimination to prevention, testing, treatment barriers and to attitudes on preventive antiretrovirals

By on .

In the global AIDS epidemic, it is the illustration of a vicious circle: People in situations that leave them the most vulnerable to getting HIV have the least access to protection. They have the highest prevalence of the virus that leads to AIDS. Then they have the least access to care. That may not be […]

HIV prevention: on the verge of transformation

By on .

A look at the recent AIDS Vaccine 2012 Conference shows range of prevention developments The following is a guest post from Margaret McGlynn, president and CEO of the International AIDS Vaccine Initiative (IAVI) and William Snow, director of the Global HIV Vaccine Enterprise. More than 1,000 HIV researchers and other professionals involved in HIV prevention […]

Study reveals effective preventive dose, pain drug for tuberculosis treatment, bad news and new steps in Uganda . . . and more

By on .

New approaches to disease treatment and prevention, as well as failures in old approaches are part of what we’re reading this week . . .   NIH-Funded analysis estimates effective PrEP dosing for men who have sex with men: An analysis of data from the iPrEx study looked at the amount of the antiretroviral medicine […]

Thai trial yield continues with news vaccine changed virus

By on .

The vaccine that showed a vaccine can prevent HIV infection also has shown that the vaccine changed the virus in people who did become infected, according to research revealed today in the first plenary session of AIDS Vaccine 2012. The findings were the third revelation from a study that first generated excitement in the AIDS […]

AIDS Vaccine 2012 will highlight scope of promising prevention advances

By on .

With a completed trial in Thailand that offered evidence a vaccine could be developed to protect people from HIV, emerging science identifying antibodies against HIV, and a current trial testing a novel vaccine combination against the virus potentially producing more information in the next year, this is an exciting time to hold a conference, organizers […]